JC viremia in natalizumab-treated patients with multiple sclerosis.
作者信息
Major Eugene O, Frohman Elliot, Douek Daniel
出版信息
N Engl J Med. 2013 Jun 6;368(23):2240-1. doi: 10.1056/NEJMc1214233.
Abstract
摘要
相似文献
1
JC viremia in natalizumab-treated patients with multiple sclerosis.那他珠单抗治疗的多发性硬化症患者中的 JC 病毒血症
N Engl J Med. 2013 Jun 6;368(23):2240-1. doi: 10.1056/NEJMc1214233.
2
More on JC viremia in natalizumab-treated patients with multiple sclerosis.关于那他珠单抗治疗的多发性硬化症患者的JC病毒血症的更多内容。
N Engl J Med. 2013 Sep 26;369(13):1280. doi: 10.1056/NEJMc1308784.
3
More on JC viremia in natalizumab-treated patients with multiple sclerosis.更多关于那他珠单抗治疗的多发性硬化症患者的JC病毒血症的情况。
N Engl J Med. 2013 Sep 26;369(13):1279-80. doi: 10.1056/NEJMc1308784.
4
JCV detection in multiple sclerosis patients treated with natalizumab.JC 病毒在接受那他珠单抗治疗的多发性硬化症患者中的检测。
J Neurol. 2010 Jun;257(6):954-8. doi: 10.1007/s00415-009-5444-4. Epub 2010 Jan 7.
5
Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence.两名接受那他珠单抗治疗的继姐妹发生进行性多灶性白质脑病：一个耐人寻味的巧合。
Mult Scler. 2017 Feb;23(2):300-303. doi: 10.1177/1352458516670734.
6
Asymptomatic reactivation of JC virus in patients treated with natalizumab.接受那他珠单抗治疗的患者中JC病毒的无症状再激活
N Engl J Med. 2009 Sep 10;361(11):1067-74. doi: 10.1056/NEJMoa0904267.
7
The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy.JC 病毒抗体指数测量在进行性多灶性白质脑病中的临床效用。
Acta Neurol Scand. 2017 Nov;136 Suppl 201:37-44. doi: 10.1111/ane.12840.
8
Molecular diagnostic tests to predict the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients.预测那他珠单抗治疗的多发性硬化症患者发生进行性多灶性白质脑病风险的分子诊断测试。
Mol Cell Probes. 2015 Feb;29(1):54-62. doi: 10.1016/j.mcp.2014.11.007. Epub 2014 Dec 5.
9
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.近一半使用那他珠单抗的巴西多发性硬化症患者JC病毒DNA呈阳性。
Arq Neuropsiquiatr. 2013 Oct;71(10):780-2. doi: 10.1590/0004-282X20130121.
10
Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of Spanish Multiple Sclerosis patients treated with natalizumab.在接受那他珠单抗治疗的一组西班牙多发性硬化症患者中，检测其外周血单核细胞、血清和尿液中的抗JCV抗体及JCV DNA水平。
J Neuroimmune Pharmacol. 2013 Dec;8(5):1277-86. doi: 10.1007/s11481-013-9496-y. Epub 2013 Aug 25.
引用本文的文献
1
Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy.进行性多灶性白质脑病：发病机制、诊断工具以及对治疗反应的潜在生物标志物。
Neurology. 2023 Oct 17;101(16):700-713. doi: 10.1212/WNL.0000000000207622. Epub 2023 Jul 24.
2
Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy.qPCR 与 ddPCR 定量检测进展性多灶性白质脑病患者脑脊液中 JC 多瘤病毒的比较。
Viruses. 2022 Jun 8;14(6):1246. doi: 10.3390/v14061246.
3
Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses.那他珠单抗的药代动力学和药效学评估：迈向个体化剂量
Front Neurol. 2021 Oct 7;12:716548. doi: 10.3389/fneur.2021.716548. eCollection 2021.
4
Biology of Polyomavirus miRNA.多瘤病毒微小RNA的生物学特性
Front Microbiol. 2021 Apr 6;12:662892. doi: 10.3389/fmicb.2021.662892. eCollection 2021.
5
Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 2: From the National Multiple Sclerosis Society Case Conference Proceedings.在患进行性多灶性白质脑病（PML）后存活的情况下治疗多发性硬化症：针对救援、缓解和康复的不同策略 患者2：源自美国国家多发性硬化症协会病例会议记录
Neurol Neuroimmunol Neuroinflamm. 2020 Dec 15;8(1). doi: 10.1212/NXI.0000000000000930. Print 2021 Jan.
6
Inadequate Immune Humoral Response against JC Virus in Progressive Multifocal Leukoencephalopathy Non-Survivors.进展性多灶性白质脑病死亡病例对 JC 病毒的免疫体液反应不足。
Viruses. 2020 Dec 2;12(12):1380. doi: 10.3390/v12121380.
7
Role of LFA-1 integrin in the control of a lymphocytic choriomeningitis virus (LCMV) infection.LFA-1 整合素在淋巴细胞性脉络丛脑膜炎病毒（LCMV）感染控制中的作用。
Virulence. 2020 Dec;11(1):1640-1655. doi: 10.1080/21505594.2020.1845506.
8
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.免疫调节治疗引起的衰老和淋巴细胞变化影响多发性硬化症患者发生 PML 的风险。
Mult Scler. 2018 Jul;24(8):1014-1022. doi: 10.1177/1352458518775550. Epub 2018 May 18.
9
JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus.JC 病毒 DNA 检测与那他珠单抗治疗多发性硬化症患者外周血中 CD8 效应细胞积累相关，与 JC 病毒血清状态无关。
Biomed Res Int. 2018 Feb 27;2018:5297980. doi: 10.1155/2018/5297980. eCollection 2018.
10
Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.了解免疫调节治疗多发性硬化症患者进行性多灶性白质脑病的风险：鸟瞰图。
Front Immunol. 2018 Feb 2;9:138. doi: 10.3389/fimmu.2018.00138. eCollection 2018.
本文引用的文献
1
Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.在那他珠单抗治疗期间和与那他珠单抗相关的进行性多灶性白质脑病中，JC 病毒特异性 T 细胞应答的变化。
PLoS Pathog. 2012;8(11):e1003014. doi: 10.1371/journal.ppat.1003014. Epub 2012 Nov 8.
2
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.抗 JC 病毒抗体在一个大型德国那他珠单抗治疗多发性硬化症队列中。
Neurology. 2012 May 29;78(22):1736-42. doi: 10.1212/WNL.0b013e3182583022. Epub 2012 May 16.
3
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.纳武利尤单抗相关进行性多灶性白质脑病的风险。
N Engl J Med. 2012 May 17;366(20):1870-80. doi: 10.1056/NEJMoa1107829.
4
JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab.JC 病毒在多发性硬化症患者接受那他珠单抗治疗后进展性多灶性白质脑病中的持续存在。
Ann Neurol. 2010 Sep;68(3):384-91. doi: 10.1002/ana.22137.
Zotero 插件